Caratteristiche di base dei pazienti con insufficienza cardiaca e impairment cognitivo lieve nel trial Cog-HF.

BACKGROUND: Dementia and heart failure (HF) are two major epidemics that adversely influence each other, yet few studies have explored strategies to prevent cognitive decline in HF. The Reducing Cognitive impairment by management of Heart Failure as a Modifiable Risk Factor (Cog-HF) trial is a randomized controlled trial assessing whether a disease management program (DMP) compared to usual care can mitigate cognitive decline in HF patients with mild cognitive impairment (MCI). This report describes the baseline characteristics of patients enrolled in Cog-HF and their comparability to recent Japanese HF registries. METHODS: Patients with HF and MCI, defined as a Montreal Cognitive Assessmen